39.17
1.09%
-0.43
시간 외 거래:
39.17
Rhythm Pharmaceuticals Inc. (RYTM) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
7.69%
24.23
|
22.50 | 19.22 | 11.47 | 8.79 |
Cost Of Revenue |
34.04%
3.233
|
2.412 | 2.236 | 1.421 | 1.028 |
Gross Profit |
4.52%
21.00
|
20.09 | 16.98 | 10.05 | 7.762 |
Operating Expenses
|
2.78%
62.27
|
64.05 | 63.59 | 62.58 | 49.87 |
Interest Income/Expense |
44.49%
4.55
|
3.149 | 3.303 | 3.061 | 3.011 |
Benefits Costs and Expenses |
0.95%
65.67
|
66.30 | 65.83 | 63.65 | 51.28 |
Costs And Expenses |
1.44%
65.50
|
66.46 | 65.83 | 64.00 | 50.89 |
Operating Income/Loss |
6.12%
-41.27
|
-43.95 | -46.60 | -52.53 | -42.10 |
Nonoperating Income/Loss |
208.86%
-0.172
|
0.158 | -0.099 | 0.352 | -0.39 |
Income/Loss From Continuing Operations Before Tax |
5.38%
-41.44
|
-43.80 | -46.70 | -52.18 | -42.49 |
Income Tax Expense/Benefit |
46.74%
0.196
|
0.368 | - | - | - |
Income/Loss From Continuing Operations After Tax |
5.73%
-41.63
|
-44.16 | -46.70 | -52.18 | -42.49 |
Net Income/Loss
|
5.73%
-41.63
|
-44.16 | -46.70 | -52.18 | -42.49 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.10%
0.5183
|
57.87 | 56.87 | 56.71 | 1.4082 |
Diluted Average Shares |
99.10%
0.5183
|
57.87 | 56.87 | 56.71 | 1.4082 |
Basic Earnings Per Share |
7.89%
-0.70
|
-0.76 | -0.82 | -0.92 | -0.74 |
Diluted Earnings Per Share |
7.89%
-0.70
|
-0.76 | -0.82 | -0.92 | -0.74 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):